Management of Hypoalbuminemia in Cirrhotic Patients

Indications for Albumin Therapy

The American Association for the Study of Liver Diseases recommends administration of 6-8g of albumin per liter of ascites drained for large-volume paracentesis to prevent circulatory dysfunction and renal impairment 1, 4
The European Association for the Study of the Liver suggests that high-risk patients with spontaneous bacterial peritonitis (bilirubin >4 mg/dL or serum creatinine >1 mg/dL) should receive 1.5 g/kg albumin at diagnosis and 1 g/kg at day 3 1
The American College of Gastroenterology recommends albumin administration combined with vasopressors as the gold standard treatment for hepatorenal syndrome 3
The Society of Critical Care Medicine found that 5% albumin has shown higher rates of shock reversal and improved 1-week survival compared to normal saline in sepsis-induced hypotension 3

The American College of Radiology recommends 6-8g of albumin per liter of ascites removed for large-volume paracentesis 1, 6
The Infectious Diseases Society of America suggests 1.5 g/kg albumin at diagnosis, followed by 1 g/kg at day 3 for spontaneous bacterial peritonitis 1
The American Association for the Study of Liver Diseases found that long-term therapy for ascites with weekly infusions (25 g/week for one year, then biweekly) may improve survival and decrease ascites recurrence 6

Regular assessment of serum albumin levels is recommended 3
Monitoring for signs of fluid overload, especially in patients receiving repeated albumin infusions, is crucial 3
Assessing response to therapy through clinical parameters (reduction in ascites, edema) is important 1, 6
Monitoring renal function, especially in patients at risk for hepatorenal syndrome, is necessary 1, 3

The American College of Gastroenterology suggests that long-term branched-chain amino acids therapy may improve bilirubin levels, Child-Pugh scores, albumin levels, and survival rates in cirrhotic patients 1
The European Society for Clinical Nutrition and Metabolism recommends a dietary protein supplementation of 1.2-1.5 g/kg/day for cirrhotic patients with ascites 1
The American Association for the Study of Liver Diseases emphasizes the importance of treating the underlying liver disease for long-term management of hypoalbuminemia 1
The National Kidney Foundation recommends a salt restriction of ≤5 g/day (sodium 2 g/day, 88 mmol/day) 1